Request to Join
has invited you to join this group
Richard T. Ellison III, MD, is Professor of Medicine, Microbiology, and Physiological Systems in the Division of Infectious Diseases and Immunology at the University of Massachusetts Medical School, Worcester. His research interests include nosocomial infections, HIV disease, infection control, and control and treatment of infections caused by antibiotic-resistant bacteria. He has pursued basic investigations into innate host defenses against bacterial pathogens and into novel antimicrobial agents active against antibiotic-resistant bacteria. A hospital epidemiologist, Dr. Ellison has focused his investigations on treating hospital-acquired infections and HIV disease. He is a past president of the Massachusetts Infectious Diseases Society. He has written for NEJM Journal Watch Infectious Diseases and served as Deputy Editor from the publication’s launch in 1998 until becoming Editor-in-Chief in 2016.
Davidson Hamer received his MD degree from the University of Vermont College of Medicine, completed an internal medicine residency at the Washington Hospital Center, and an infectious disease fellowship at Tufts-New England Medical Center. Dr. Hamer’s clinical interests include emerging infections, tropical and travel medicine. In addition to his international research on maternal, newborn, and child health, and antimicrobial resistance, , Dr. Hamer has served as the principal investigator since 2014 for GeoSentinel, a global surveillance network of 65 sites in 29 countries that uses returning travelers, immigrants, and refugees as sentinels of disease emergence and transmission patterns throughout the world.
Dr. Stephen Baum is currently emeritus professor of medicine and of microbiology & immunology, as well as senior advisor for student affairs. After joining the faculty as a research associate in 1968, Dr. Baum became, in rapid succession, director of the infectious disease service at Einstein Hospital, director of Einstein’s Medical Scientist Training Program (MD-PhD), one of the original chiefs of the department of medicine’s division of infectious diseases, and director of the office of graduate education. After moving to Beth Israel Medical Center in 1987 to chair its department of medicine, he returned to Einstein in 2007, where he began his role as dean for student affairs. . For the past decade, his sage counsel has guided Einstein students along their journey through medical school, into residency and, ultimately, into practice. Dr. Baum is a member of the editorial boards of Clinical Infectious Diseases, Infectious Diseases and Journal Watch Infectious Diseases, and author of numerous book chapters and peer-reviewed articles. Early in his career he was chosen as Career Scientist by the Health Research Council of the City of New York. His excellence in teaching medical students has led to being elected twice to the Leo M. Davidoff Society―in 1980 and in 1996. He also was presented Einstein’s Lifetime Achievement Award for Excellence in Teaching in 2008. Dr. Baum earned his undergraduate degree at Cornell University and his medical degree at New York University School of Medicine. He completed his internship and residency at Harvard Medical Service – Boston City Hospital, and spent two years as a research associate at the NIH’s National Institute of Allergy and Infectious Diseases. He is a Fellow of The American College of Physicians and the infectious Diseases Society of America.
Patrícia Brasil, MD, PhD. I am a Professor of Tropical Medicine and Clinical Research at FIOCRUZ for graduate and post-graduate curricula and work as an Infectious Diseases (ID) Clinical Researcher/Attending Physician. My main area of research in the past 9 years has been acute febrile illnesses (AFI), with most studies centered in dengue and malaria until 2015. Established in 2007, the AFI clinic is a sentinel service of emerging and re-emerging infectious diseases, as we utilize a flowchart of syndromic investigations, in collaboration with national reference laboratories for molecular diagnostics. The application of this protocol permitted us to identify the beginning of an epidemic of a new exanthematic disease, with Zika virus identified as the etiologic agent. We have a large outpatient clinical service and to date have seen hundreds of cases of ZIKV infection in our patients.
Dr. Gabriela Paz-Bailey received her MD from the University of San Carlos in Guatemala and her PhD and Masters in Tropical Medicine from the London School of Hygiene and Tropical Medicine. She is a senior epidemiologist at the Centers for Disease Control and Prevention. Dr. Paz-Bailey is a known expert on using public health research and surveillance to improve the prevention of HIV and other infectious diseases. In addition to her work on HIV/AIDS, she has worked on outbreak responses including Zika and Ebola. She has designed and implemented clinical trials to evaluate viral shedding in genital secretions.